Compare COHU & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COHU | KURA |
|---|---|---|
| Founded | 1947 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | N/A |
| Metric | COHU | KURA |
|---|---|---|
| Price | $24.15 | $11.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $29.33 | $25.00 |
| AVG Volume (30 Days) | 649.2K | ★ 2.1M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $424,848,000.00 | $104,029,000.00 |
| Revenue This Year | $14.95 | $68.63 |
| Revenue Next Year | $12.03 | $141.59 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.57 | $5.41 |
| 52 Week High | $29.08 | $12.49 |
| Indicator | COHU | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 58.07 |
| Support Level | $21.14 | $11.42 |
| Resistance Level | $24.40 | $12.27 |
| Average True Range (ATR) | 0.95 | 0.87 |
| MACD | 0.14 | 0.05 |
| Stochastic Oscillator | 87.24 | 66.61 |
Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.